Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 3/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.49 |
| ▸ | THRA | P10827 | 5/20 | 0.45 |
| ▸ | THRB | P10828 | 5/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL444543 | 0.92 | S1PR2 (0.44) | S1PR2S1PR1S1PR3LPAR2THRA | |
| SCHEMBL13963208 | 0.92 | S1PR2 (0.44) | S1PR2S1PR1S1PR3LPAR2THRA | |
| SCHEMBL1201128 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL1201162 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL1201515 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL1201657 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL1201460 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL4864512 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL1200630 | 0.90 | THRA (0.45) | THRATHRB | |
| SCHEMBL96240 | 0.90 | THRA (0.45) | THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9284348-B2 | Method for synthesis of peptide using a carrier | JITSUBO CO., LTD. (JP) | 2016-03-15 | — | — | US | disclosed |
| US-20140107319-A1 | CARRIER FOR SEPARATION, METHOD FOR SEPARATION OF COMPOUND, AND METHOD FOR SYNTHESIS OF PEPTIDE USING THE CARRIER | JITSUBO CO., LTD. (JP) | 2014-04-17 | — | — | US | disclosed |
| US-8293948-B2 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent | JITSUBO CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20120108788-A1 | REAGENT FOR ORGANIC SYNTHESIS AND METHOD OF ORGANIC SYNTHESIS REACTION WITH THE REAGENT | JITSUBO CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107319-A1 | CARRIER FOR SEPARATION, METHOD FOR SEPARATION OF COMPOUND, AND METHOD FOR SYNTHESIS OF PEPTIDE USING THE CARRIER | CCKBR, CCKAR, VIP | S1PR2 1755/4885S1PR1 1933/4885S1PR3 2178/4885 |
| US-20120108788-A1 | REAGENT FOR ORGANIC SYNTHESIS AND METHOD OF ORGANIC SYNTHESIS REACTION WITH THE REAGENT | COASY, OSTC, OGA | S1PR2 2628/4885S1PR1 2868/4885S1PR3 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.